Literature DB >> 1452347

Characterization of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin.

C Petersen1, J Gut, P S Doyle, J H Crabb, R G Nelson, J H Leech.   

Abstract

Cryptosporidium parvum, a zoonotic Apicomplexan pathogen, causes profound diarrhea, malnutrition, and dehydration in patients with AIDS. A less severe, self-limited disease occurs in immunocompetent individuals, particularly children, animal handlers, and residents of the developing world. Very little is known about the biology of the organism, the pathophysiology of the disease process, or the mechanism of protective immunity. There is no effective therapy for cryptosporidiosis, but hyperimmune bovine colostrum raised against Cryptosporidium oocysts and sporozoites has ameliorated infection and disease in some patients with AIDS, and a variety of monoclonal antibodies, as well as hyperimmune bovine colostrum, have significantly reduced cryptosporidial infection of mice and calves. We report here the identification and initial characterization of a > 900,000-M(r) Cryptosporodium sporozoite glycoprotein (GP900) that is a prominent antigen recognized by protective hyperimmune bovine colostral immunoglobulin. Three of six murine anticryptosporidial monoclonal antibodies reacted with GP900, indicating that the molecule is highly immunogenic in mice as well as in cows. GP900 is Triton X-100 soluble and N glycosylated. Western blotting of the N-deglycosylated protein, detected with antibodies eluted from recombinant clones expressing a partial GP900 fusion protein, suggested that the polypeptide backbone of the glycoprotein has an M(r) of < 190,000. GP900 is encoded by a single-copy gene that resides on the largest Cryptosporidium chromosome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452347      PMCID: PMC258288          DOI: 10.1128/iai.60.12.5132-5138.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum.

Authors:  S Tzipori; D Roberton; C Chapman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-15

2.  Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) oocyst and sporozoite antigens recognized by bovine colostral antibodies.

Authors:  M Tilley; R Fayer; A Guidry; S J Upton; B L Blagburn
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice.

Authors:  R Fayer; A Guidry; B L Blagburn
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Infectivity and neutralization of Cryptosporidium parvum sporozoites.

Authors:  M W Riggs; L E Perryman
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

5.  Production of monoclonal antibodies by hybridomas sensitized to sporozoites of Plasmodium berghei.

Authors:  H D Danforth; G H Campbell; M F Leef; R L Beaudoin
Journal:  J Parasitol       Date:  1982-12       Impact factor: 1.276

6.  Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves.

Authors:  R Fayer; C Andrews; B L Ungar; B Blagburn
Journal:  J Parasitol       Date:  1989-06       Impact factor: 1.276

7.  Identification of a particular antigen from a parasite cDNA library using antibodies affinity purified from selected portions of Western blots.

Authors:  J A Beall; G F Mitchell
Journal:  J Immunol Methods       Date:  1986-02-12       Impact factor: 2.303

8.  Nebulin cDNAs detect a 25-kilobase transcript in skeletal muscle and localize to human chromosome 2.

Authors:  H Stedman; K Browning; N Oliver; M Oronzi-Scott; K Fischbeck; S Sarkar; J Sylvester; R Schmickel; K Wang
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

9.  Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice.

Authors:  M J Arrowood; J R Mead; J L Mahrt; C R Sterling
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

10.  Cryptosporidiosis in immunocompetent patients.

Authors:  J S Wolfson; J M Richter; M A Waldron; D J Weber; D M McCarthy; C C Hopkins
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

View more
  22 in total

1.  Obtaining hyperimmune anti-Cryptosporidium parvum ovine colostrum. A study of the humoral immune response in immunized sheep.

Authors:  S Martín-Gómez; M A Alvarez-Sánchez; F A Rojo-Vázquez
Journal:  Parasitol Res       Date:  2005-11-16       Impact factor: 2.289

2.  Molecular karyotype analysis of Cryptosporidium parvum: evidence for eight chromosomes and a low-molecular-size molecule.

Authors:  D S Blunt; N V Khramtsov; S J Upton; B A Montelone
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

3.  Parasites and immunotherapy: with or against?

Authors:  Hossein Yousofi Darani; Morteza Yousefi; Marzieh Safari; Rasool Jafari
Journal:  J Parasit Dis       Date:  2014-08-31

4.  Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.

Authors:  W B Strong; J Gut; R G Nelson
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Recombinant proteins of Cryptosporidium parvum induce proliferation of mesenteric lymph node cells in infected mice.

Authors:  Inderpal Singh; Cynthia Theodos; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Evidence that surface proteins Sn14 and Sn16 of Sarcocystis neurona merozoites are involved in infection and immunity.

Authors:  F T Liang; D E Granstrom; X M Zhao; J F Timoney
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 7.  Human immune responses in cryptosporidiosis.

Authors:  Anoli Borad; Honorine Ward
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

Review 8.  Cryptosporidium: genomic and biochemical features.

Authors:  Stanley Dean Rider; Guan Zhu
Journal:  Exp Parasitol       Date:  2008-12-31       Impact factor: 2.011

9.  Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.

Authors:  P S Doyle; J Crabb; C Petersen
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.

Authors:  M W Riggs; V A Cama; H L Leary; C R Sterling
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.